Chemed Corporation reports developments across two wholly owned subsidiaries: VITAS Healthcare, a provider of hospice and palliative end-of-life care, and Roto-Rooter, which provides plumbing, drain cleaning, water restoration and related services to residential and commercial customers.
Company news commonly covers quarterly operating results, VITAS patient revenue, admissions and census measures, Roto-Rooter service demand, franchise territory acquisitions, credit facility updates, share repurchases, new hospice-care locations and investor conference presentations.
Chemed (NYSE: CHE) will present at the UBS 2026 Global Healthcare Conference on November 9, 2026, at approximately 8:45 a.m. ET.
The presentation will take place at PGA National Resort in Palm Beach Gardens, Florida. A live webcast and presentation materials will be available through Chemed's Investor Relations website. The replay will be available within 24 hours and accessible for 90 days.
Chemed (CHE) reported third-quarter 2026 revenue of $690.9 million, with earnings growth led by its VITAS hospice business. Revenue rose 10.6% year over year; GAAP diluted earnings per share increased 22.2% to $5.45, and adjusted diluted EPS rose 28.1% to $6.75.
VITAS revenue increased 12.2% to $457.4 million, with average daily census up 9.4%. Its adjusted EBITDA, excluding Medicare Cap billing limits, rose 31.4% to $92.5 million. Roto-Rooter revenue grew 7.5% to $233.5 million, but adjusted EBITDA fell 2.5% to $48.2 million. Roto-Rooter reacquired California franchise territories for approximately $62.5 million.
Chemed repurchased $66.0 million of shares during the quarter. At September 30, cash was $48.4 million and long-term debt was $236.0 million. The company expects full-year adjusted EPS at or slightly above the high end of its previously issued 2026 guidance.
Chemed (NYSE: CHE) will release its third-quarter 2026 financial results on October 27, 2026, after the close of trading. The results cover the quarter ended September 30, 2026. A conference call and webcast will follow at 10 a.m. ET on October 28, 2026, to discuss the quarterly results and provide a business update.
Chemed (CHE), through its wholly owned subsidiary Roto-Rooter Services Company, acquired the largest independent Roto-Rooter franchise for $60.6 million.
The acquired franchise serves a population of about 11 million people and previously generated annual revenue between $50.0 million and $55.0 million. The territories include Northern San Diego, Palm Springs, Ventura, Bakersfield, Lancaster, Fresno, Monterey, Stockton, Modesto, Manteca and Sacramento in California. Chemed, listed on the New York Stock Exchange and headquartered in Cincinnati, operates two wholly owned subsidiaries, VITAS Healthcare and Roto-Rooter, which it describes as national leaders in hospice care and plumbing and drain cleaning services respectively. The company includes standard cautionary language regarding forward-looking statements and associated risks.
Chemed (CHE)/b) will present at the Jefferies 2026 Healthcare Services and Technology Conference on September 15, 2026, at about 10:55 a.m. CT in Nashville.The presentation at the 1 Hotel will be webcast live, with access and related materials available through the Chemed website’s Investor Relations section. A replay of the webcast will be posted within 24 hours and remain accessible for 90 days. Chemed, headquartered in Cincinnati, operates two wholly owned subsidiaries: VITAS Healthcare, a large U.S. hospice care provider, and Roto-Rooter, a national plumbing and drain cleaning service provider.
Chemed Corporation (NYSE:CHE) declared a quarterly cash dividend of $0.70 per share, payable on September 3, 2026, to shareholders of record on August 17, 2026. The dividend is a $0.10, or 17%, increase over the $0.60 paid in June 2026 and represents Chemed’s 221st consecutive quarterly dividend in 55 years as a public company.
Chemed (NYSE: CHE) reported second-quarter 2026 revenue up 8.8% year over year to $673.3 million, with GAAP diluted EPS rising 43.7% to $5.13 and adjusted diluted EPS up 41.9% to $6.06. VITAS net patient revenue grew 11.9% to $443.3 million, driven by 6.1% higher days-of-care and a 2.4% Medicare rate increase, while VITAS adjusted EBITDA excluding Medicare Cap rose 20.6% to $80.6 million with an 18.2% margin.
Roto-Rooter revenue increased 3.3% to $229.9 million, with adjusted EBITDA essentially flat at $48.5 million and margin down 77 bps to 21.1%. Chemed entered a new five-year $450 million revolving credit agreement and ended the quarter with $40.2 million cash and $140.0 million long-term debt. The company repurchased 210,000 shares for $89.8 million in the quarter and reduced its share count about 10.5% over 12 months. Full-year 2026 adjusted EPS guidance was raised to $25.00–$25.75, mainly reflecting VITAS outperformance and lower expected Medicare Cap.
Chemed (NYSE: CHE) will release its second quarter 2026 financial results on Tuesday, July 28, 2026, after the NYSE close.
The company will host a conference call and webcast on Wednesday, July 29, 2026 at 10 a.m. ET to discuss results and provide a business update, with live and replay access via its investor relations website.
Chemed (NYSE: CHE) announced that its wholly owned subsidiary Roto-Rooter Services Company acquired a formerly independent Roto-Rooter franchise serving 21 counties in south Texas for approximately $12.0 million. The territory includes Corpus Christi, McAllen, Laredo, and Brownsville, expanding Roto-Rooter’s company-operated footprint.
Chemed (NYSE: CHE) held its 2026 annual stockholders’ meeting, where stockholders elected nine directors and ratified PricewaterhouseCoopers as independent accountants for 2026. A non-binding proposal on executive compensation was not approved.
The Board declared a $0.60 quarterly cash dividend, payable June 16, 2026, to stockholders of record on May 28, 2026. This is Chemed’s 220th consecutive quarterly dividend over 55 years as a public company. Chemed operates VITAS Healthcare and Roto-Rooter.